for

Madrigal Pharmaceuticals Enters into Exclusive Global License Agreement for Oral GLP-1 Receptor Agonist with CSPC Pharmaceutical Group Limited

License agreement supports Madrigal’s pipeline strategy to develop innovative combination treatments for MASH, anchored by its foundational therapy Rezdiffra™ (resmetirom)…

6 months ago

Dr. Falk Pharma and Allianthera (Suzhou) Biopharmaceuticals Forge Strategic Partnership for Novel AhR Agonist Development

Freiburg (Germany), Suzhou (China) and Boston (USA), July 30, 2025:  Dr. Falk Pharma GmbH and Allianthera (Suzhou) Biopharmaceuticals Co., Ltd.…

6 months ago

Altizon Launches APEX Alliance for Azure channel partners

Altizon Launches APEX Alliance — Altizon Partner EXcellence Alliance — to Accelerate Industrial AI on Microsoft Azure PRINCETON, N.J., July…

6 months ago

Leo Cancer Care Receives FDA 510(k) Clearance for Marie – A Revolutionary Upright Radiotherapy Platform

MIDDLETON, Wis., July 29, 2025 /PRNewswire/ -- Leo Cancer Care, a leader in upright radiotherapy solutions, today announces that its flagship…

6 months ago

Blockchain for Good Alliance Leads Global Digital Cooperation at UN IGF 2025

DUBAI, UAE, July 29, 2025 /PRNewswire/ -- The Blockchain for Good Alliance (BGA), a flagship non-profit founded by Bybit and…

6 months ago

Tata Communications Paves Way for Amazon Web Services’ Advanced AI-Optimised Network in India

MUMBAI, India, July 29, 2025 /PRNewswire/ -- Tata Communications, a leading global communications technology player, in collaboration with Amazon Web Services…

6 months ago

FROM THE ALZHEIMER’S ASSOCIATION INTERNATIONAL CONFERENCE 2025: ALZHEIMER’S ASSOCIATION RELEASES ITS FIRST CLINICAL PRACTICE GUIDELINE FOR BLOOD-BASED BIOMARKER TESTS

Key Takeaways At AAIC 2025, the Alzheimer's Association released the first in a series of clinical practice guidelines for the…

6 months ago

Alamar Biosciences and the German Center for Neurodegenerative Diseases (DZNE) partner for Landmark Proteomic Profiling study in the Rhineland Study Cohort

NULISAseq™ CNS Disease Panel 120 and Inflammation Panel 250 to Power Biomarker Discovery in 23,000 Longitudinal Samples FREMONT, Calif., July…

6 months ago

OXIO Recognized with Frost & Sullivan’s 2025 Global Telecom-as-a-Service Transformational Innovation Leadership Recognition for Redefining Connectivity Through Cloud-Native Innovation

Recognized for its cloud-native Telecom-as-a-Service (TaaS) platform and core network, OXIO leads digital transformation and customer-centric innovation in the global…

6 months ago

Winners in Second Annual Stevie Awards for Technology Excellence Announced

Winners to Be Celebrated at a Ceremony in New York on September 16 FAIRFAX, Va., July 29, 2025 /PRNewswire/ --…

6 months ago